MKS Instruments stock hits 52-week high at $147.53

Published 06/11/2025, 15:42
MKS Instruments stock hits 52-week high at $147.53

MKS Instruments Inc (MKSI) stock reached a new 52-week high of $147.53, recently climbing further to $154.39, marking a significant milestone for the company. This achievement reflects a robust 36.66% increase over the past year, with an impressive 93.45% surge in the past six months alone, underscoring the company’s strong performance and investor confidence. With a market capitalization of $10.29 billion, MKSI has maintained dividend payments for 15 consecutive years. The surge to this 52-week high highlights MKS Instruments’ upward trajectory in the market, as it continues to build on its successes and expand its influence in the industry. Investors and analysts alike are closely monitoring this upward trend, as the company navigates the challenges and opportunities of the current economic landscape. With a P/E ratio of 35.93 and a beta of 1.94, MKSI shows both premium valuation and higher volatility than the broader market. According to InvestingPro analysis, the stock appears to be trading above its Fair Value, though its overall financial health score is rated as "GOOD." InvestingPro offers 8 more insights and a comprehensive Research Report on MKSI, helping investors make more informed decisions.

In other recent news, MKS Instruments reported strong financial results for the second quarter of 2025, surpassing analysts’ expectations. The company achieved an earnings per share of $1.77, exceeding the forecasted $1.62, and reported revenues of $973 million, beating the anticipated $931.11 million. In addition to its earnings news, MKS Instruments announced a quarterly cash dividend of $0.22 per share, payable in December to shareholders of record in late November.

Analysts have taken note of these developments, with KeyBanc maintaining an Overweight rating and a $160 price target on the stock, citing potential in the company’s strategic focus on semiconductor manufacturing. Meanwhile, Needham raised its price target to $136, maintaining a Buy rating and expressing optimism about the company’s semiconductor business growth prospects. Reports have also surfaced suggesting that MKS Instruments is considering selling a $1 billion specialty chemical division to further concentrate on its semiconductor supply operations. These recent developments highlight the company’s strategic shifts and positive financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.